-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LJ/DsvQA6KQVmWz4lTeHMBboAQteKr+Yg0IyEozd9dMWF0H/gtYUCXqSkkxkHyv5 Z4LgYX3UjSJ6+DAuByRSKQ== 0001193125-04-132270.txt : 20040805 0001193125-04-132270.hdr.sgml : 20040805 20040805115208 ACCESSION NUMBER: 0001193125-04-132270 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040804 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20040805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERIGON INC CENTRAL INDEX KEY: 0000903129 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLES & PASSENGER CAR BODIES [3711] IRS NUMBER: 954318554 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21810 FILM NUMBER: 04953870 BUSINESS ADDRESS: STREET 1: 5462 IRWINDALE AVENUE CITY: IRWINDALE STATE: CA ZIP: 91760- BUSINESS PHONE: 6268157400 MAIL ADDRESS: STREET 1: 5462 IRWINDALE AVE CITY: IRWINDALE STATE: CA ZIP: 91706 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 4, 2004

 


 

AMERIGON INCORPORATED

(Exact name of registrant as specified in its charter)

 


 

California   0-21810   95-4318554

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

500 Town Center Drive, Suite 200, Dearborn, MI   48126-2716
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (313) 336-3000

 



Items 1 – 6. Not applicable.

 

Item 7. Financial Statements and Exhibits

 

Exhibit 99.1: Company news release dated August 4, 2004.

 

Items 8 – 11. Not applicable.

 

Item 12. Results of Operations and Financial Condition.

 

On August 4, 2004, Amerigon Incorporated publicly announced its three and six month earnings for the period ended June 30, 2004. A copy of the Company’s news release announcing the earnings is filed as Exhibit 99.1 to this report and is incorporated in this report by reference. The information in this Item 12 and the attached exhibit shall not be deemed filed for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly stated by specific reference in such filing.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMERIGON INCORPORATED

By:

 

 

/s/    Sandra L. Grouf        


   

Sandra L. Grouf,

   

Corporate Secretary and Treasurer

 

Date: August 5, 2004


Exhibit Index

   
99.1   Company news release dated August 4, 2004.
EX-99.1 2 dex991.htm COMPANY NEWS RELEASE Company news release

EXHIBIT 99.1

 

NEWS RELEASE for August 4, 2004 at 7:30 AM EDT

Contact:

  Allen & Caron Inc
    Jill Bertotti (investors)
    jill@allencaron.com
    Len Hall (media)
    len@allencaron.com
    (949) 474-4300

 

AMERIGON REPORTS SECOND QUARTER, SIX-MONTH RESULTS

 

Strong Year-over-Year Bottom-Line Improvement for Both Periods

 

DEARBORN, MI (August 4, 2004) . . . Amerigon Incorporated (Nasdaq:ARGN) today reported a significant improvement in bottom-line results for the second quarter and six months ended June 30, 2004 when compared with the prior year periods. President and Chief Executive Officer Daniel R. Coker said that in addition to achieving year-over-year gains in profit during the quarter, the Company continued its focus on increasing the penetration of its patented Climate Control Seat (CCS) systems to automotive and seat manufacturers worldwide and on achieving its first full year of profitability in 2004.

 

Revenues for the 2004 second quarter increased 53 percent to $8.6 million, up from $5.6 million for the year-earlier period. Net income in this year’s second quarter improved to $295,000, or $0.02 per basic share and $0.01 per fully diluted share, compared with a net loss of $609,000, or a $0.06 loss per share in the prior year period. Gross margin as a percentage of revenue for this year’s second quarter rose to 25.9 percent, up from 24.8 percent for the prior year period, reflecting improved product mix and cost reduction activity. The 2004 second quarter results included approximately $69,000 of development expense for the Company’s BSST subsidiary that was not fully reimbursed by BSST customers.

 

“Achieving our third consecutive quarter of profitability is evidence of the significant progress we have made throughout the organization and the continuing appeal of CCS,” said Coker. “Automotive manufacturers and consumers are increasingly selecting CCS for their vehicles, and we continue to expand our presence in the worldwide automotive market. We are working closely with virtually every major automotive manufacturer and seat supplier to incorporate CCS in future vehicle lines. We have just initiated shipments of CCS for the new 2005 Nissan Gloria luxury sports sedan sold in Japan.”

 

The Gloria, which will offer CCS as an option, shares the same features as the Infiniti M45, which is sold in the U.S., and is the fourth vehicle manufactured by the Nissan Motor Company to offer CCS.

 

As has been widely reported, many automotive manufacturers experienced softness in vehicle sales during the second quarter, including sales of large vehicles such as SUVs (Sport Utility

 

MORE-MORE-MORE


AMERIGON REPORTS SECOND QUARTER, SIX-MONTH RESULTS

Page 2-2-2

 

Vehicles), due in part to increasingly high fuel prices in the U.S. and higher interest rates. “This had an impact on the sales of several vehicles offering CCS, and we expect this softness in the automotive market to continue for the balance of this year, particularly in the third quarter,” Coker added. “As a result, we expect to see growth in unit volume and revenue in the range of 15 to 20 percent for 2004. At these levels, we believe we remain well positioned to achieve our goal of being profitable for the full year.”

 

For the first six months of 2004, revenues increased 62 percent to $17.6 million, up from $10.9 million for the year-earlier period. Net income in this year’s first six months improved to $596,000, or $0.05 per basic share and $0.03 per fully diluted share, compared with a net loss of $1.5 million, or a $0.14 loss per share in the prior year period. Gross margin as a percentage of revenue for the first six months of 2004 rose to 24.6 percent, up from 22.7 percent for the prior year period. Results for this year’s first six months included approximately $136,000 of development expense for the Company’s BSST subsidiary that was not fully reimbursed by BSST customers compared to $258,000 for the year-earlier period.

 

Selling, general and administrative (SG&A) expenses in this year’s second quarter and six months increased 7 percent and 9 percent, respectively, to $1.4 million and $2.7 million compared with the prior year periods as the Company added headcount to support domestic and international customer service and marketing efforts.

 

Research and development expenses for the second quarter and six months of 2004 decreased 18 percent and 27 percent, respectively, to $561,000 and $1.2 million from comparable periods in the prior year. This decrease was due primarily to lower prototype costs associated with the Company’s next generation CCS system, MTM, which was launched in the latter part of 2003 and to customer funding received by Amerigon’s subsidiary, BSST. This customer support sustains BSST’s development of advanced thermoelectric technology and reduces significantly the Amerigon financial support required.

 

The June 30, 2004 balance sheet showed cash and cash equivalents of $4.0 million, total assets of $12.9 million, shareholder equity of $6.4 million and no bank debt. Subsequent to the close of the second quarter, Amerigon received an additional $3.4 million as a result of the exercise of warrants.

 

There are currently 15 vehicle lines from five major automotive manufacturers offering CCS. The vehicle lines currently offering CCS are Lincoln Navigator SUV, Lexus LS 430 luxury sedan, Toyota Celsior luxury sedan, Infiniti M45 luxury sports sedan, Ford Expedition SUV Eddie Bauer edition, Lincoln Aviator SUV, Infiniti Q45 luxury sedan, Lincoln LS luxury sedan, Cadillac XLR roadster, Cadillac Escalade ESV SUV, Mercury Monterey minivan, Cadillac Sedan Deville, Hyundai Equus luxury sedan, Nissan Cima luxury sedan and Nissan Gloria mid-sized sedan.

 

Conference Call

 

As previously announced, Amerigon is conducting a conference call to review the financial results today at 11:30 AM EDT (Eastern). The dial-in number for the call is 1-800-253-6872. A live webcast and archive of the call can be accessed at www.amerigon.com and www.viavid.net.

 

MORE-MORE-MORE


AMERIGON REPORTS SECOND QUARTER, SIX-MONTH RESULTS

Page 3-3-3

 

About Amerigon

 

Amerigon designs, develops and markets its proprietary Climate Control Seat (CCS) products for sale to automotive and truck original equipment manufacturers (OEMs). CCS enhances individual driver and passenger comfort in virtually all climatic conditions by providing cooling and heating to seat occupants, as desired, through an active thermoelectric-based temperature management system. Amerigon’s subsidiary, BSST, is engaged in developing thermoelectric devices (TED) with more efficiency than currently available devices and has development contracts with several partners to expand the market for TED-based automotive and non-automotive products. Amerigon maintains sales and technical support centers in Los Angeles, Detroit, Japan, Germany and England.

 

Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company’s actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, necessary additional financing may be unavailable, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to the Amerigon’s Securities and Exchange Commission filings and reports, including but not limited to its Form 10-QSB for the period ending June 30, 2004 and its Form 10-K for the year ended December 31, 2003.

 

TABLES FOLLOW


AMERIGON REPORTS SECOND QUARTER, SIX-MONTH RESULTS

Page 4-4-4

 

AMERIGON INCORPORATED

CONSOLIDATED STATEMENT OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

    

Three Months

Ended June 30,


   

Six Months

Ended June 30,


 
     2004

   2003

    2004

   2003

 

Product revenues

   $ 8,630    $ 5,644     $ 17,591    $ 10,890  

Cost of sales

     6,394      4,246       13,267      8,417  
    

  


 

  


Gross margin

     2,236      1,398       4,324      2,473  

Operating costs and expenses:

                              

Research and development

     561      684       1,183      1,629  

Selling, general and administrative

     1,436      1,346       2,652      2,430  
    

  


 

  


Total operating costs and expenses

     1,997      2,030       3,835      4,059  

Operating income (loss)

     239      (632 )     489      (1,586 )

Interest income

     6      —         7      —    

Interest expense

     —        (30 )     —        (53 )

Other income

     50      53       100      105  
    

  


 

  


Net income (loss)

   $ 295    $ (609 )   $ 596    $ (1,534 )
    

  


 

  


Basic net income (loss) per share

   $ 0.02    $ (0.06 )   $ 0.05    $ (0.14 )
    

  


 

  


Diluted net income (loss) per share

   $ 0.01    $ (0.06 )   $ 0.03    $ (0.14 )
    

  


 

  


Weighted average number of shares -basic

     12,689      10,785       12,554      10,778  
    

  


 

  


Weighted average number of shares -diluted

     20,564      10,785       20,343      10,778  
    

  


 

  


 

MORE-MORE-MORE


AMERIGON REPORTS SECOND QUARTER, SIX-MONTH RESULTS

Page 5-5-5

 

AMERIGON INCORPORATED

 

CONSOLIDATED BALANCE SHEET

(In thousands, except share data)

 

     June 30,
2004


    December 31,
2003


 
     (Unaudited)        
ASSETS                 

Current Assets:

                

Cash & cash equivalents

   $ 3,973     $ 844  

Accounts receivable, less allowance of $56 and $56, respectively

     4,742       5,882  

Inventory

     2,311       2,498  

Prepaid expenses and other assets

     335       224  
    


 


Total current assets

     11,361       9,448  

Property and equipment, net

     1,232       1,300  

Deferred exclusivity fee

     146       293  

Patent costs, net of accumulated amortization of $5 and $4 respectively

     192       193  
    


 


Total assets

   $ 12,931     $ 11,234  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY                 

Current Liabilities:

                

Accounts payable

   $ 4,028     $ 4,258  

Accrued liabilities

     1,124       868  

Deferred manufacturing agreement – current portion

     200       200  
    


 


Total current liabilities

     5,352       5,326  

Deferred manufacturing agreement – long term portion

     1,150       1,250  

Minority interest in subsidiary

     19       19  
    


 


Total liabilities

     6,521       6,595  
    


 


Shareholders’ equity:

                

Preferred stock:

                

Series A – no par value; convertible; 9,000 shares authorized, 9,000 issued and outstanding at June 30, 2004 and December 31 2003; liquidation preference of $11,520 at June 30, 2004 and December 31, 2003

     8,267       8,267  

Common stock:

                

No par value; 30,000,000 shares authorized, 12,980,000 and 12,411,000 issued and outstanding at June 30, 2004 and December 31, 2003

     47,911       46,758  

Paid-in capital

     20,202       20,180  

Accumulated deficit

     (69,970 )     (70,566 )
    


 


Total shareholders’ equity

     6,410       4,639  
    


 


Total liabilities and shareholders’ equity

   $ 12,931     $ 11,234  
    


 


 

# # # #

-----END PRIVACY-ENHANCED MESSAGE-----